When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Campylobacter infection

Evidence last reviewed: 21 May 2026
Topic last updated: 14 Apr 2026

Summary

Definition

History and exam

Key diagnostic factors

  • abdominal pain
  • diarrhea
Full details

Other diagnostic factors

  • prodrome of headache, myalgias, chills, fever
  • nausea and vomiting
Full details

Risk factors

  • age <5 years
  • age ≥65 years
  • recent foreign travel
  • eating raw or undercooked foods
  • exposure to poultry, cattle, sheep, or other farm animals
  • immunocompromise
  • HIV infection
  • male sex
  • untreated water
  • drinking unpasteurized (raw) milk
  • close contact with infected person
  • use of proton pump inhibitors (PPIs) or H2 antagonists
Full details

Diagnostic tests

1st tests to order

  • stool microscopy
  • stool culture
  • white blood cell count
Full details

Tests to consider

  • serum Campylobacter serology
  • blood culture
  • intestinal biopsy
  • fecal microscopy
  • culture-independent diagnostic test (CIDT)
Full details

Treatment algorithm

ACUTE

gastroenteritis

Contributors

Authors

Eli D. Ehrenpreis, MD, FACG, AGAF

Research Director

Internal Medicine Residency

Advocate Lutheran General Hospital

Park Ridge

IL

Professor of Medicine

Wake Forest University Medical School

Winston-Salem

NC

Divulgaciones

EDE is CEO, owner, and shareholder for E2Bio Life Sciences LLC. E2Bio Life Sciences LLC has developed Bocaliner, an FDA-registered class 1 medical device designed to enhance the efficacy of topical medications applied to the oral cavity. EDE is the inventor and owner of patents for this device. EDE is also a CEO of G.I. Pharmaceuticals Inc., which has medical treatments for oral leukoplakia designed to prevent oral cancer, and a new medication for anal pruritus. G.I. Pharmaceuticals Inc. is involved with the development of educational programs for students and medical trainees.

Agradecimientos

Dr Eli D. Ehrenpreis would like to gratefully acknowledge the assistance of Dr Olivia Foy, who contributed to this update. Dr Eli D. Ehrenpreis would like to gratefully acknowledge Dr Gregory Juckett, Dr Kristin Furfari, Professor Sarah O'Brien, and Dr Olivia Foy the previous contributors to this topic.

Divulgaciones

OF, GJ, and KF declare that they have no competing interests.

Revisores por pares

Justin T. Kupec, MD

Assistant Professor

Section of Digestive Diseases

Department of Medicine

West Virginia University

Morgantown

WV

Divulgaciones

JTK declares that he has no competing interests.

Stephen Morris-Jones, MBBS, MRCPath

Consultant in Infectious Diseases and Clinical Microbiology

University College London Hospitals NHS Foundation Trust

Windeyer Institute of Medical Sciences

London

UK

Divulgaciones

SMJ declares that he has no competing interests.

Michael Bennish, MD

Senior Associate

Department of Population, Family and Reproductive Health

Bloomberg School of Public Health

Johns Hopkins University

Baltimore

MD

Divulgaciones

MB declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Centers​ for Disease Control and Prevention. Campylobacter infection (Campylobacteriosis). Jan 2025 [internet publication].Texto completo

Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80.Texto completo  Resumen

Government of British Columbia. Laboratory. Nov 2023 [internet publication].Texto completo

Riddle MS, DuPont HL, Connor BA. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. 2016 May;111(5):602-22.Texto completo  Resumen

World Gastroenterology Organisation (WGO). WGO practice guideline: acute diarrhea. 2012 [internet publication].Texto completo

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Campylobacter infection images
  • Diferenciales

    • Salmonella gastroenteritis
    • Shigella gastroenteritis
    • Yersinia gastroenteritis
    Más Diferenciales
  • Guías de práctica clínica

    • Laboratory guidelines
    • Infectious diarrhea - guideline for investigation
    Más Guías de práctica clínica
  • Folletos para el paciente

    Diarrhea in adults

    Diarrhea in children

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad